Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.6650 (-2.67%) ($7.6650 - $7.9700) on Fri. Nov. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.35% (three month average) | RSI | 68 | Latest Price | $7.6650(-2.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.7% a day on average for past five trading days. | Weekly Trend | EDIT advances 13.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(81%) XBI(80%) ARKK(70%) IBUY(69%) IBB(67%) | Factors Impacting EDIT price | EDIT will decline at least -2.175% in a week (0% probabilities). TBT(-26%) UUP(-14%) VXX(-12%) VIXM(2%) UNG(5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.175% (StdDev 4.35%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.26(-7.2%) | 10 Day Moving Average | $7.69(-0.33%) | 20 Day Moving Average | $7.14(7.35%) | To recent high | -16% | To recent low | 22.4% | Market Cap | $476m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |